Apellis Pharmaceuticals, Inc. (APLS) Stock Total Returns
Growth of $10,000 chart
2021-05-17 to 2026-05-15 to
$
%
%
Loading chart…
Investment Performance
Final Value
$7,733
Total Return
-22.67%
CAGR
-5.02%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.51% |
| Median | +0.36% |
| Best | +141.54% |
| Worst | -73.41% |
| % of Windows Positive | 50.7% |
1-Year (252 Trading Days)
| Average | -4.57% |
| Median | -22.37% |
| Best | +150.81% |
| Worst | -66.55% |
| % of Windows Positive | 35.5% |
3-Year (756 Trading Days)
| Average | -45.63% |
| Median | -50.67% |
| Best | +12.69% |
| Worst | -73.74% |
| % of Windows Positive | 1.0% |
Risk Metrics
| Maximum Drawdown | -82.47% |
| Average Drawdown | -45.57% |
| Drawdown Duration | 733 Trading Days (Unrecovered) |
| Sortino Ratio | 0.58 |
| Calmar Ratio | -0.06 |
| CVaR (5%) | -9.78% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +63.34% (+277.14% ann.) | +$6333.60 | $0.00 | $0.00 | $0.00 |
| 2025 | -21.28% | $2127.86 | $0.00 | $0.00 | $0.00 |
| 2024 | -46.69% | $4669.23 | $0.00 | $0.00 | $0.00 |
| 2023 | +15.76% | +$1576.10 | $0.00 | $0.00 | $0.00 |
| 2022 | +9.37% | +$936.97 | $0.00 | $0.00 | $0.00 |
| 2021 | -17.34% | $1734.26 | $0.00 | $0.00 | $0.00 |
| 2020 | +86.81% | +$8680.60 | $0.00 | $0.00 | $0.00 |
| 2019 | +132.15% | +$13214.56 | $0.00 | $0.00 | $0.00 |
| 2018 | -39.22% | $3921.66 | $0.00 | $0.00 | $0.00 |
| 2017 partial | +54.67% (+2318.70% ann.) | +$5466.86 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 9, 2017 – February 19, 2020 | +187.31% | +58.93% | +$18731.29 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -38.62% | -99.62% | $3862.35 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +30.80% | +54.04% | +$3080.28 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +19.62% | +18.53% | +$1962.04 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +4.54% | +4.83% | +$453.90 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -21.20% | -12.06% | $2120.21 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – May 15, 2026 | +15.16% | +8.91% | +$1515.58 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.